Yearly Publication Trends - pegylation

Year	Publication Count
2024	78
2023	179
2022	116
2021	105
2020	86
2019	82
2018	67
2017	84
2016	83
2015	67
2014	71

Relevant Publications

Characteristics of the Antitumor Effect of Doxorubicin and Pegylated Hyaluronidase on Models of Rat Brain Tumors.

Issue Release: 2024

Cytokine-induced killer cells-mediated chlorin e6-loaded gold nanostars for targeted NIR imaging and immuno-photodynamic combination therapy for lung cancer.

Issue Release: 2024

A Concise Review on Effect of PEGylation on the Properties of Lipid-Based Nanoparticles.

Issue Release: 2024

The use of proteins and peptides-based therapy in managing and preventing pathogenic viruses.

Issue Release: 2024

Combination of PEGylation and Cationization on Phospholipid-Coated Cyclosporine Nanosuspensions for Enhanced Ocular Drug Delivery.

Issue Release: 2024

A journey through the history of PEGylated drug delivery nanocarriers.

Issue Release: 2024

A Super-Antifouling Electrochemical Biosensor for Protein Detection in Complex Biofluids Based on PEGylated Multifunctional Peptide.

Issue Release: 2024

A change of rhodocytin\'s suprastructure turns the agonist into an antagonist of tumor cell induced platelet aggregation.

Issue Release: 2024

Study of uricase-polynorbornene conjugates derived from grafting-from ring-opening metathesis polymerization.

Issue Release: 2024

Size-based characterization of dendrigraft poly(L-lysine) by free solution capillary electrophoresis using polyelectrolyte multilayer coatings.

Issue Release: 2024

Microfluidics-enabled fluorinated assembly of EGCG-ligands-siTOX nanoparticles for synergetic tumor cells and exhausted t cells regulation in cancer immunotherapy.

Issue Release: 2024

Hybridized quantum dot, silica, and gold nanoparticles for targeted chemo-radiotherapy in colorectal cancer theranostics.

Issue Release: 2024

Polysarcosine as PEG Alternative for Enhanced Camptothecin-Induced Cancer Immunogenic Cell Death.

Issue Release: 2024

Genetically Encoded XTEN-based Hydrogels with Tunable Viscoelasticity and Biodegradability for Injectable Cell Therapies.

Issue Release: 2024

Research progress on the PEGylation of therapeutic proteins and peptides (TPPs).

Issue Release: 2024

Bimetallic PtPd Atomic Clusters as Apoptosis/Ferroptosis Inducers for Antineoplastic Therapy through Heterogeneous Catalytic Processes.

Issue Release: 2024

Neutralizing PAMPs that Trigger Cytokine Release from THP-1 Monocytes.

Issue Release: 2024

Modifying peptide/lipid-associated nucleic acids (PLANAs) for CRISPR/Cas9 ribonucleoprotein delivery.

Issue Release: 2024

Recent progress on polySarcosine as an alternative to PEGylation: Synthesis and biomedical applications.

Issue Release: 2024

The underlying mechanism of nuclear and mitochondrial DNA damages in triggering cancer incidences: Insights into proteomic and genomic sciences.

Issue Release: 2024

Why are Collaborative Care Models Important in Pharma?

What Role Does Regulatory Affairs Play?

How Does Cellular Stress Impact Drug Development?

What is an Abbreviated New Drug Application (ANDA)?

What Are the Challenges in Managing Chronic Conditions?

How Do Collaborative Care Models Work?

What Education and Training Do Pharmacists Need?

What Should Be Included in Patient Education Materials?

What Challenges Do Pharmacists Face?

What Are the Therapeutic Approaches to Mitigate Cellular Stress?

Yearly Publication Trends - pegylation

Relevant Publications

Relevant Topics

Partnered Content Networks

Relevant Topics